GoodRx partners with pharmacy benefits managers (PBMs) who negotiate discounted prescription prices directly with pharmacies.

The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report.

GoodRx (NASDAQ:GDRX) is facing lawsuits from several independent pharmacies who are accusing the company of working with ...